Matan raises NIS 31m. from industry

Local businesses and industry contributed over NIS 31 million to help various societies through the Matan welfare organization in 2005, Matan said Monday.

By AVI KRAWITZ
January 31, 2006 08:23

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Local businesses and industry contributed over NIS 31 million to help various societies through the Matan welfare organization in 2005, Matan said Monday. Contributions included NIS 17.5m. of donations from Israel Corporation, Israel Chemicals, Zim Shipping and Services and its workers, earmarked for the "Israeli Companies for a Healthy Israel Fund" to help the sick purchase medicines not in their health baskets. The fund has, to date, raised NIS 35m. In addition to the funding, Matan said the participating companies' workers had volunteered approximately 14,000 hours in various social organizations.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS